ArticleBMC cancer2024

Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study.

Zhen-Yuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.